Navigation Links
Cambrex Reports Second Quarter of 2011 Results
Date:8/2/2011

p>$.25$.22Diluted Earnings/(Loss) per Share of Common Stock:   Income from Continuing Operations

$.26$.18   (Loss)/Income from Discontinued Operations, Net of Tax

$

  (0.01)$.04   Net Income

$.25$.22Weighted Average Shares OutstandingBasic29,43329,324Diluted29,49029,402CAMBREX CORPORATIONConsolidated Balance SheetsAs of June 30, 2011 and December 31, 2010(in thousands)June 30,December 31,Assets20112010Cash and Cash Equivalents

$

40,911 $

29,614Trade Receivables, net38,27339,025Inventories, net67,96161,408Prepaid Expenses and Other Current Assets7,8915,082  Total Current Assets155,036135,129Property, Plant and Equipment, net152,057150,483Goodwill40,17737,694Intangible Assets, net4,8984,687Investment in Partially-Owned Affiliate18,87819,709Other Non-Current Assets2,9944,049  Total Assets

$

374,040 $

351,751Liabilities and Stockholders' EquityAccounts Payable

$

19,619 $

19,480Accrued Expenses and Other Current Liabilities36,92633,503Current Portion of Long-term Debt116,400-  Total Current Liabilities172,94552,983Long-term Debt-115,900Deferred Income Taxes18,79017,893Accrued Pension and Postretirement Benefits40,20643,921Other Non-Current Liabilities13,33213,419  Total Liabilities

$

245,273 $

244,116  Stockholders’ Equity

$

128,767 $

107,635  Total Liabilities and Stockholders’ Equity

$

374,040 $

351,751CAMBREX CORPORATIONReconciliation of EBITDAFor the Quarters and Six Months Ended June 30, 2011 and 2010(in thousands)Second Quarter 2011Second Quarter 2010Operating Profit

$

7,294$

6,908Depreciation and Amortization5,8785,226EBITDA

$

13,172$

12,134Six Months 2011Six Months 2010Operating Profit

$

12,601$

10,620Depreciation and Amortization11,60310,610EBITDA

$

24,204$

21,
'/>"/>

SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cambrex Reports Third Quarter 2010 Results
2. Cambrex Reports Fourth Quarter and Full Year 2009 Results
3. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
4. Cambrex Reports First Quarter 2009 Results
5. Cambrex Receives Notice Regarding NYSE Listing
6. Cambrex Reports Third Quarter 2008 Results
7. Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
8. Gen-Probe Reports Financial Results for the Second Quarter of 2011
9. Neurocrine Biosciences Reports Second Quarter 2011 Results
10. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
11. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... HealthTronics, Inc. , a leading ... and services, has signed a distribution agreement through ... for its high precision laser technology. ... mobile, surgical technology—offering more choices for healthcare providers ... will make available Clinicon’s FDA-cleared SureLase™ CO2 Laser ...
(Date:9/19/2014)... 19, 2014  InterMune, Inc. (Nasdaq: ITMN ... of Understanding to settle the litigation in the Delaware ... of Merger dated as of August 22, 2014, among ... As one term of the Memorandum of Understanding, the ... in the attached exhibit reflecting the amendment to the ...
(Date:9/19/2014)... at NYU Langone Medical Center have found a way ... for turning adult cells into so-called pluripotent stem cells ... the new technique in mice, the researchers increased the ... by more than 20-fold compared with the standard method. ... thus should generally accelerate research aimed at using stem ...
(Date:9/19/2014)... 19, 2014 Follow us ... to revolutionize the world has attracted diverse players ... small start-ups. The early years of nanotechnology development ... due to the high risks involved, which deterred ... for this evolving technology have been growing over ...
Breaking Biology Technology:HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 2InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 3InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 4InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 5InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 6InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 7InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 8InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 9InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 10InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 11InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 12InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 13InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 14InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 15InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 16InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 17InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 18InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 19NYU Langone scientists report reliable and highly efficient method for making stem cells 2NYU Langone scientists report reliable and highly efficient method for making stem cells 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
... Ferring Pharmaceuticals Inc.,has announced that its hyaluronic ... the title sponsor of the EUFLEXXA National,Senior Games ... Year,Award., "This is such a tremendous opportunity ... Alex Drigan, Product Manager, EUFLEXXA(TM). "We,support all that ...
... MOUNTAIN VIEW, Calif., Jan. 28 Clontech Laboratories,Inc., ... announced the,imminent (February 20, 2008) release of its ... issue of Clontechniques, the company,s quarterly,newsletter. Based on ... Stanford, the ProteoTuner systems use a unique technology ...
... for Continued Development of CNDO103 as ... ... today,announced the publication of data demonstrating that the Bcl-2 inhibitor,Apogossypol, effectively ... than Gossypol in vivo in mice., Published online in Blood ...
Cached Biology Technology:Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award 2Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award 3Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award 4Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems 2Study Shows Coronado Biosciences' Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models 2Study Shows Coronado Biosciences' Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models 3
(Date:9/18/2014)... that when people are too stressed they are often ... Brain Mind Institute (BMI) at EPFL have just highlighted ... chronic stress and the loss of social skills and ... a synaptic regulatory molecule in the brain. This was ... . , Carmen Sandi,s team went to look ...
(Date:9/18/2014)... probably the ultimate form of camouflage: you don,t just ... strategy is not as uncommon as you might think. ... USA, explains that the larval life stages of many ... of the anatomy that most creatures cannot make transparent. ... to shield each individual eye unit with an opaque ...
(Date:9/18/2014)... their entire lives nestling in the protective tentacles of ... they sometimes travel hundreds of kilometres across the open ... fish has been predicted, this is the first time ... populations has been observed. , Dr Steve Simpson, Senior ... University of Exeter, and colleagues from the Australian Research ...
Breaking Biology News(10 mins):How stress tears us apart 2Transparent larvae hide opaque eyes behind reflections 2Expedition finds Nemo can travel great distances to connect populations 2Expedition finds Nemo can travel great distances to connect populations 3
... century, state-of-the-art anti-aging technologies may extend human lifespans at ... social and economic challenges, says biologist Shripad Tuljapurkar of ... advances would have major implications for the global community ... Morrison Professor of Population Studies, will give a talk ...
... Cell reports the discovery of a gene that drives ... potential new target for countermeasures against the lethal toxin, ... the potential to protect against anthrax during the late ... therapeutic value, they added. , The team found that ...
... biologist Ernst Mayr's theory of genetic revolution , introduced ... has many detractors. , Mayr believed that genes interacted ... turn led to an interaction of natural selection with ... of evolutionary change. , Detractors of the theory object ...
Cached Biology News:World faces challenge as life expectancies lengthen, scientist says 2World faces challenge as life expectancies lengthen, scientist says 3World faces challenge as life expectancies lengthen, scientist says 4Driver of anthrax toxicity could lead to late-stage therapy 2Ernst Mayr's theory illustrated in genetic epidemiology studies 2Ernst Mayr's theory illustrated in genetic epidemiology studies 3Ernst Mayr's theory illustrated in genetic epidemiology studies 4
in vitro Translation, Accessory Products...
... RNA Quantitation Kit is one of ... the quantitation of RNA in solution. ... more sensitive than absorbance measurements. As ... detected with fluorescence microplate readers and ...
Donor Horse Serum US Origin...
... added in Dec 2005 , Quantitative ... Detection from as little as 25 pg ... available for hundreds of mammalian miRNAs , ... , Ideal for validating expression profiling ...
Biology Products: